---
document_datetime: 2025-12-29 14:03:02
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/iblias.html
document_name: iblias.html
version: success
processing_time: 0.097172
conversion_datetime: 2025-12-30 11:48:02.310805
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Iblias

[RSS](/en/individual-human-medicine.xml/67070)

##### Withdrawn

This medicine's authorisation has been withdrawn

octocog alfa Medicine Human Withdrawn

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Iblias](#news-on)
- [More information on Iblias](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 3 September 2019, the European Commission withdrew the marketing authorisation for Iblias (octocog alfa) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Bayer AG, which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Iblias was granted marketing authorisation in the EU on 18 February 2016 for treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency). The marketing authorisation was initially valid for a 5-year period. The product had not been marketed in the EU since 2018.

The European Public Assessment Report (EPAR) for Iblias is updated to indicate that the marketing authorisation is no longer valid.

Iblias : EPAR - Summary for the public

Reference Number: EMEA/H/C/004147

English (EN) (664.7 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/overview/iblias-epar-summary-public_en.pdf)

[Other languages (22)](#file-language-dropdown-135)

български (BG) (728.12 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/bg/documents/overview/iblias-epar-summary-public_bg.pdf)

español (ES) (1.17 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/es/documents/overview/iblias-epar-summary-public_es.pdf)

čeština (CS) (708.58 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/cs/documents/overview/iblias-epar-summary-public_cs.pdf)

dansk (DA) (633.88 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/da/documents/overview/iblias-epar-summary-public_da.pdf)

Deutsch (DE) (635.46 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/de/documents/overview/iblias-epar-summary-public_de.pdf)

eesti keel (ET) (631.72 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/et/documents/overview/iblias-epar-summary-public_et.pdf)

ελληνικά (EL) (731.97 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/el/documents/overview/iblias-epar-summary-public_el.pdf)

français (FR) (635.97 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/fr/documents/overview/iblias-epar-summary-public_fr.pdf)

hrvatski (HR) (656.29 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/hr/documents/overview/iblias-epar-summary-public_hr.pdf)

italiano (IT) (633.83 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/it/documents/overview/iblias-epar-summary-public_it.pdf)

latviešu valoda (LV) (707.69 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/lv/documents/overview/iblias-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (659.06 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/lt/documents/overview/iblias-epar-summary-public_lt.pdf)

magyar (HU) (701.65 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/hu/documents/overview/iblias-epar-summary-public_hu.pdf)

Malti (MT) (709.33 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/mt/documents/overview/iblias-epar-summary-public_mt.pdf)

Nederlands (NL) (634.13 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/nl/documents/overview/iblias-epar-summary-public_nl.pdf)

polski (PL) (707.63 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/pl/documents/overview/iblias-epar-summary-public_pl.pdf)

português (PT) (634.9 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/pt/documents/overview/iblias-epar-summary-public_pt.pdf)

română (RO) (655.77 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/ro/documents/overview/iblias-epar-summary-public_ro.pdf)

slovenčina (SK) (706.67 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sk/documents/overview/iblias-epar-summary-public_sk.pdf)

slovenščina (SL) (701.11 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sl/documents/overview/iblias-epar-summary-public_sl.pdf)

Suomi (FI) (633.26 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/fi/documents/overview/iblias-epar-summary-public_fi.pdf)

svenska (SV) (663.78 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sv/documents/overview/iblias-epar-summary-public_sv.pdf)

Iblias : EPAR - Risk-management-plan summary

Reference Number: EMA/1562/2016

English (EN) (615.14 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/rmp-summary/iblias-epar-risk-management-plan-summary_en.pdf)

## Product information

Iblias : EPAR - Product Information

English (EN) (833.63 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 27/04/2018

[View](/en/documents/product-information/iblias-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-767)

български (BG) (2.24 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/bg/documents/product-information/iblias-epar-product-information_bg.pdf)

español (ES) (809.65 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/es/documents/product-information/iblias-epar-product-information_es.pdf)

čeština (CS) (1.5 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/cs/documents/product-information/iblias-epar-product-information_cs.pdf)

dansk (DA) (1.16 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/da/documents/product-information/iblias-epar-product-information_da.pdf)

Deutsch (DE) (813.96 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/de/documents/product-information/iblias-epar-product-information_de.pdf)

eesti keel (ET) (802.89 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/et/documents/product-information/iblias-epar-product-information_et.pdf)

ελληνικά (EL) (1.97 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/el/documents/product-information/iblias-epar-product-information_el.pdf)

français (FR) (1.23 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/fr/documents/product-information/iblias-epar-product-information_fr.pdf)

hrvatski (HR) (1.21 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/hr/documents/product-information/iblias-epar-product-information_hr.pdf)

íslenska (IS) (973.6 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/is/documents/product-information/iblias-epar-product-information_is.pdf)

italiano (IT) (810.4 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/it/documents/product-information/iblias-epar-product-information_it.pdf)

latviešu valoda (LV) (1.57 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/lv/documents/product-information/iblias-epar-product-information_lv.pdf)

lietuvių kalba (LT) (910.21 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/lt/documents/product-information/iblias-epar-product-information_lt.pdf)

magyar (HU) (1.49 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/hu/documents/product-information/iblias-epar-product-information_hu.pdf)

Malti (MT) (1.89 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/mt/documents/product-information/iblias-epar-product-information_mt.pdf)

Nederlands (NL) (835.73 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/nl/documents/product-information/iblias-epar-product-information_nl.pdf)

norsk (NO) (760.73 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/no/documents/product-information/iblias-epar-product-information_no.pdf)

polski (PL) (1.55 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/pl/documents/product-information/iblias-epar-product-information_pl.pdf)

português (PT) (825.77 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/pt/documents/product-information/iblias-epar-product-information_pt.pdf)

română (RO) (1.25 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/ro/documents/product-information/iblias-epar-product-information_ro.pdf)

slovenčina (SK) (1.61 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/sk/documents/product-information/iblias-epar-product-information_sk.pdf)

slovenščina (SL) (1.51 MB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/sl/documents/product-information/iblias-epar-product-information_sl.pdf)

Suomi (FI) (815.83 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/fi/documents/product-information/iblias-epar-product-information_fi.pdf)

svenska (SV) (825.87 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

27/04/2018

[View](/sv/documents/product-information/iblias-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** A31/0002 10/11/2017

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Iblias : EPAR - All Authorised presentations

English (EN) (575.64 KB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-696)

български (BG) (596.48 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/bg/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_bg.pdf)

español (ES) (575.54 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/es/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_es.pdf)

čeština (CS) (601.52 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/cs/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (574.47 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/da/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (574.02 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/de/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (574.22 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/et/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (617.28 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/el/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_el.pdf)

français (FR) (574.01 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/fr/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (585.23 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/hr/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (574.53 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/is/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_is.pdf)

italiano (IT) (573.99 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/it/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (604.11 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/lv/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (585.62 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/lt/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (600.67 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/hu/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (602.23 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/mt/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (575.64 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/nl/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (575.56 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/no/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_no.pdf)

polski (PL) (602.55 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/pl/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_pl.pdf)

português (PT) (575.48 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/pt/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_pt.pdf)

română (RO) (587.68 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/ro/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (600.53 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sk/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (589.67 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sl/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (574.13 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/fi/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (574.27 KB - PDF)

**First published:**

09/03/2016

**Last updated:**

09/03/2016

[View](/sv/documents/all-authorised-presentations/iblias-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Iblias Active substance octocog alfa International non-proprietary name (INN) or common name octocog alfa Therapeutic area (MeSH) Hemophilia A Anatomical therapeutic chemical (ATC) code B02BD02

### Pharmacotherapeutic group

Antihemorrhagics

### Therapeutic indication

Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).

## Authorisation details

EMA product number EMEA/H/C/004147 Marketing authorisation holder

Bayer AG

51368 Leverkusen Germany

Marketing authorisation issued 18/02/2016 Revision 4

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Iblias : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (643.27 KB - PDF)

**First published:** 08/07/2016

**Last updated:** 27/04/2018

[View](/en/documents/procedural-steps-after/iblias-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Iblias-H-C-4147-A31-0002 : EPAR - Assessment Report - Article 31

Adopted

Reference Number: EMA/763977/2017

English (EN) (905.9 KB - PDF)

**First published:** 05/12/2017

**Last updated:** 05/12/2017

[View](/en/documents/variation-report/iblias-h-c-4147-a31-0002-epar-assessment-report-article-31_en.pdf)

## Initial marketing authorisation documents

Iblias : EPAR - Public assessment report

Adopted

Reference Number: EMA/CHMP/71742/2016

English (EN) (2.47 MB - PDF)

**First published:** 09/03/2016

**Last updated:** 09/03/2016

[View](/en/documents/assessment-report/iblias-epar-public-assessment-report_en.pdf)

CHMP summary of opinion for Iblias

Adopted

Reference Number: EMA/CHMP/774757/2015

English (EN) (623.74 KB - PDF)

**First published:** 18/12/2015

**Last updated:** 18/12/2015

[View](/en/documents/smop-initial/chmp-summary-opinion-iblias_en.pdf)

#### News on Iblias

[Factor VIII medicines: no clear and consistent evidence of difference in risk of inhibitor development between classes](/en/news/factor-viii-medicines-no-clear-consistent-evidence-difference-risk-inhibitor-development-between-classes) 15/09/2017

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 December 2015](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-14-17-december-2015) 18/12/2015

#### More information on Iblias

- [EMEA-001064-PIP01-10-M03 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-001064-pip01-10-m03)
- [Factor VIII - referral](/en/medicines/human/referrals/factor-viii)

**This page was last updated on** 18/02/2020

## Share this page

[Back to top](#main-content)